• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小鼠骨肉瘤模型中化疗与手术的时机安排

Timing of chemotherapy and surgery in a murine osteosarcoma model.

作者信息

Bell R S, Roth Y F, Gebhardt M C, Bell D F, Rosenberg A E, Mankin H J, Suit H D

机构信息

Sarcoma Biology Laboratory, St. Michael's Hospital, Toronto, Ontario, Canada.

出版信息

Cancer Res. 1988 Oct 1;48(19):5533-8.

PMID:3166399
Abstract

The sequential use of chemotherapy and surgery in the treatment of osteosarcoma developed in an empirical fashion without the benefit of investigations in animal models. The MGH-OGS murine osteosarcoma is a transplantable tumor that resembles the human disease with respect to histology, local invasiveness, metastatic characteristics, tumor ploidy, and its response to chemotherapy. We have used this tumor model to investigate the efficacy of preoperative, perioperative, and postoperative chemotherapy on the development of pulmonary metastases in three different experimental protocols. In each experimental design, perioperative chemotherapy demonstrated a significant advantage in preventing systemic relapse.

摘要

骨肉瘤治疗中化疗和手术的序贯使用是凭经验发展而来的,没有动物模型研究的支持。MGH-OGS小鼠骨肉瘤是一种可移植肿瘤,在组织学、局部侵袭性、转移特征、肿瘤倍体及其对化疗的反应方面与人类疾病相似。我们使用这个肿瘤模型,通过三种不同的实验方案来研究术前、围手术期和术后化疗对肺转移发生的疗效。在每个实验设计中,围手术期化疗在预防全身复发方面显示出显著优势。

相似文献

1
Timing of chemotherapy and surgery in a murine osteosarcoma model.小鼠骨肉瘤模型中化疗与手术的时机安排
Cancer Res. 1988 Oct 1;48(19):5533-8.
2
Effect of doxorubicin on local recurrence following marginal resection in the MGH-OGS murine model.阿霉素对MGH-OGS小鼠模型边缘切除术后局部复发的影响。
J Orthop Res. 1990 Jan;8(1):105-18. doi: 10.1002/jor.1100080114.
3
Chemotherapy and surgery in a murine osteosarcoma.小鼠骨肉瘤的化疗与手术治疗
J Orthop Res. 1992 Sep;10(5):720-8. doi: 10.1002/jor.1100100514.
4
Osteogenic sarcoma of the extremity with detectable lung metastases at presentation. Results of treatment of 23 patients with chemotherapy followed by simultaneous resection of primary and metastatic lesions.初诊时伴有可检测到肺转移的肢体骨肉瘤。23例患者先接受化疗,随后同时切除原发灶和转移灶的治疗结果。
Cancer. 1997 Jan 15;79(2):245-54.
5
Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery?骨肉瘤患者仅通过化疗和取消手术就能治愈吗?
Cancer. 2002 Nov 15;95(10):2202-10. doi: 10.1002/cncr.10944.
6
9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice.9-硝基喜树碱脂质体气雾剂对小鼠黑色素瘤和骨肉瘤肺转移的治疗作用
Clin Cancer Res. 2000 Jul;6(7):2876-80.
7
Optimal timing of adjuvant chemotherapy in mouse models.小鼠模型中辅助化疗的最佳时机。
Prog Clin Biol Res. 1985;201:15-21.
8
Multidrug resistance-1 gene expression does not increase during tumor progression in the MGH-OGS murine osteosarcoma tumor model.在MGH-OGS小鼠骨肉瘤肿瘤模型中,多药耐药-1基因的表达在肿瘤进展过程中不会增加。
J Orthop Res. 2000 May;18(3):449-55. doi: 10.1002/jor.1100180318.
9
Osteosarcoma chemotherapy effect: a prognostic factor.骨肉瘤化疗效果:一个预后因素。
Semin Diagn Pathol. 1987 Aug;4(3):212-36.
10
Caffeine-assisted chemotherapy and minimized tumor excision for nonmetastatic osteosarcoma.咖啡因辅助化疗与非转移性骨肉瘤的肿瘤切除最小化
Anticancer Res. 1998 Jan-Feb;18(1B):657-66.

引用本文的文献

1
Timing of interval debulking surgery and postoperative chemotherapy after neoadjuvant chemotherapy in advanced epithelial ovarian cancer: a multicenter real-world study.新辅助化疗后间隔减瘤手术和术后化疗在晚期上皮性卵巢癌中的时机:一项多中心真实世界研究。
J Ovarian Res. 2023 Jun 27;16(1):121. doi: 10.1186/s13048-023-01164-8.
2
Novel evolutionary dynamics of small populations in breast cancer adjuvant and neoadjuvant therapy.乳腺癌辅助和新辅助治疗中小群体的新型进化动力学
NPJ Breast Cancer. 2021 Mar 11;7(1):26. doi: 10.1038/s41523-021-00230-y.
3
Timing of Adjuvant Chemoradiation in pT1-3N1-2 or pT4aN1 Esophageal Squamous Cell Carcinoma After R0 Esophagectomy.
R0食管切除术后pT1 - 3N1 - 2或pT4aN1食管鳞状细胞癌辅助放化疗的时机
Cancer Manag Res. 2020 Oct 27;12:10573-10585. doi: 10.2147/CMAR.S276426. eCollection 2020.
4
From the completion of neoadjuvant chemotherapy to surgery for colorectal cancer liver metastasis: What is the optimal timing?结直肠癌肝转移新辅助化疗后至手术的最佳时机:何时为宜?
Cancer Med. 2020 Nov;9(21):7849-7862. doi: 10.1002/cam4.3283. Epub 2020 Sep 4.
5
Prognostic Influence of the Time Interval between Surgery and Chemotherapy in Epithelial Ovarian Cancer.上皮性卵巢癌手术与化疗时间间隔的预后影响
J Cancer. 2018 Oct 18;9(22):4172-4178. doi: 10.7150/jca.27409. eCollection 2018.
6
Impact of the Time Interval from Neoadjuvant Chemotherapy to Surgery in Primary Ovarian, Tubal, and Peritoneal Cancer Patients.新辅助化疗至手术的时间间隔对原发性卵巢癌、输卵管癌和腹膜癌患者的影响。
J Cancer. 2018 Oct 18;9(21):4087-4091. doi: 10.7150/jca.26631. eCollection 2018.
7
Relationship between initiation time of adjuvant chemotherapy and survival in ovarian cancer patients: a dose-response meta-analysis of cohort studies.辅助化疗起始时间与卵巢癌患者生存的关系:队列研究的剂量反应荟萃分析。
Sci Rep. 2017 Aug 25;7(1):9461. doi: 10.1038/s41598-017-10197-1.
8
Variability in chemotherapy delivery for elderly women with advanced stage ovarian cancer and its impact on survival.晚期卵巢癌老年女性化疗给药的变异性及其对生存的影响。
Br J Cancer. 2008 Apr 8;98(7):1197-203. doi: 10.1038/sj.bjc.6604298. Epub 2008 Mar 18.
9
An orthotopic model of murine osteosarcoma with clonally related variants differing in pulmonary metastatic potential.一种具有肺转移潜能不同的克隆相关变体的小鼠骨肉瘤原位模型。
Clin Exp Metastasis. 2000;18(3):261-71. doi: 10.1023/a:1006767007547.
10
A nude mouse model of human osteosarcoma lung metastases for evaluating new therapeutic strategies.用于评估新治疗策略的人骨肉瘤肺转移裸鼠模型
Clin Exp Metastasis. 1999;17(6):501-6. doi: 10.1023/a:1006623001465.